Particle.news
Download on the App Store

Anemia Tied to Higher Alzheimer’s Biomarkers and Dementia Risk in Large Swedish Study

Researchers frame anemia as a possible prevention target that needs trials to show whether correction prevents dementia.

Overview

  • The peer-reviewed JAMA Network Open cohort of 2,282 dementia-free adults found that those with anemia faced a 1.7-times higher risk of developing dementia over about nine years.
  • Participants with low hemoglobin also showed higher blood levels of Alzheimer’s-linked proteins p-tau217, neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) at the start of the study.
  • Risk was highest when anemia occurred together with elevated biomarkers, including a 3.6-fold higher risk for people with both anemia and high NfL compared with those with neither.
  • Dementia incidence was 4.4 cases per 100 person-years in participants with anemia versus 1.7 without, after accounting for age, education, chronic diseases, supplements, and inflammation markers.
  • The authors say anemia may help stratify dementia risk because it is often treatable, though the observational design cannot prove causation and it remains unknown whether treating anemia reduces dementia.